openPR Logo
Press release

Sterile Injectable Drugs Market revenues worth US$ 657 Bn by 2024

Sterile Injectable Drugs Market revenues worth US$ 657 Bn by 2024

“The global sterile injectable drugs market will potentially achieve the revenues worth US$ 657 Bn by the end of 2024. With a compound annual growth rate of more than 7%, the market is expected to experience promising growth prospects over an eight-year forecast period, 2016-2024.” - Persistence Market Research

In a recently published report outlook titled “Sterile Injectable Drugs Market: Global Industry Analysis and Forecast, 2016-2024,” Persistence market Research projects the global market for sterile injectable drugs to witness healthy growth throughout the next eight years. Preponderance of chronic diseases, coupled with several technological advancement in novel drug delivery systems, will continue to generate the demand for sterile injectable drugs within the assessment period.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/12811

The report highlights a growing trend of small molecule injectable drugs gaining immense popularity. Moreover, fast-track FDA approvals for injectable drugs, increasing demand for injectable drug delivery, and rapid expansion of contract manufacturing facility, especially in European countries, will create attractive opportunities in near future.

The global sterile injectable drugs market is broken down on the basis of drug type, molecule type, application type, route of administration, and distribution channel.

By molecule type, among the two key segments viz. small molecule and large molecule, large molecule segment will continue to dominate – despite facing a slight drop in terms of BPS through 2024. This segment will account for over 53% share of the market value in 2024. However, overall growth of both the segments will remain promising throughout the forecast period.
Based on drug type, ‘others’ segment including drugs used to treat mental health, autoimmune diseases, and respiratory disease, will retain dominance during the forecast period. This segment will witness a robust CAGR of over 8%. Monoclonal antibodies, vaccines, and insulin will be the next key segments. Insulin segment will experience the fastest growth through 2024, followed by vaccines segment.
On the basis of application type, ‘others’ segment that includes several chronic diseases, is expected to remain dominant by the end of 2024, crossing a value of US$ 200 Bn. CVDs, cancer, and diabetes are anticipated to be the next major segments, among which CVDs segment is slated for the fastest growth at a CAGR of 10%.
By route of administration, intravenous (IV) segment currently dominates with roughly 43% share of the market value. This segment will continue to dominate but subcutaneous, the second largest segment, will possibly witness the highest CAGR of 10%.
Depending on the distribution channel, hospital pharmacies are likely to continue their dominance over the period of forecast, accounting for the revenues beyond US$ 378 Bn in 2024. Online pharmacies will possibly gain the highest popularity, witnessing the fastest growth at a CAGR of over 9%.

Regional analysis reaffirms dominance of North America

According to regional analysis, North America, Europe, and Asia Pacific will be the top three markets over 2016-2024. The highest growth will be observed in APAC, crossing US$ 150 Bn by 2024 end, followed by Europe. The Asian market will be led by China, Japan, and India.

Request Report for TOC @ https://www.persistencemarketresearch.com/methodology/12811

Key player analysis indicates a number of M&A, collaborations, and partnerships

Among all the key players competing in the global sterile injectable drugs market, Sanofi recently swapped its animal health business (Merial) with Boehringer Ingelheim’s consumer healthcare (CHC) business, in January 2017. Earlier in October 2016, the company had announced its collaboration with Oswaldo Cruz Foundation and Walter Reed Army Institute of research (WRAIR) for a development of a vaccine against Zika virus.
Pfizer Inc. acquired development and commercialization rights of AstraZeneca’s late-stage small molecule anti-infective business recently in December 2016. Whereas, GlaxoSmithKline plc opened a new global vaccine R&D center in the U.S., in December 2016.
While GILEAD SCIENCES, INC. entered into a partnership with WHO for diagnosis and treatment of Visceral Leishmaniasis, Novo Nordisk A/S received an approval from the European Commission for Fiasp, a fast-acting insulin aspart especially for treating adult diabetes.
Other key companies operating in the global sterile injectable drugs marketplace, include Baxter International Inc., AstraCeneca plc, Merck & Co., Inc., Novartis AG, and Johnson & Johnson Services, Inc.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sterile Injectable Drugs Market revenues worth US$ 657 Bn by 2024 here

News-ID: 1135750 • Views:

More Releases from Persistence Market Research Pvt.Ltd.

Dental Restoration Market Present Scenario and the Growth Prospects 2017 - 2025
Dental Restoration Market Present Scenario and the Growth Prospects 2017 - 2025
The term dental restoration covers an integrated management of oral health and restoring the oral health to a functional and esthetic state. The American Dental Association has not considered restorative dentist as a separate specialty though the dentists are able to perform man of these procedures without any additional course or certification. The dental restoration procedures depend on how difficult the procedure is and what the professional feels comfortable with.
Mobile Air Transfer Systems Market Trends and Key Developments 2017 - 2025
Mobile Air Transfer Systems Market Trends and Key Developments 2017 - 2025
Mobile air transfer system is the system used in hospitals and other medical centers that helps to reduce patient handling injury. The system provides patients with simple and comfortable transfer experience along with significantly reducing the cumulative handling effect of thousands of pounds of patients’ weight while routine transfers. To ensure the safety of hundreds of millions of people suffering from health care associated infections and abnormalities mobile air transfer
Orthopedic Veterinary Implants Market is projected to reach US$ 3,500 Mn by 2026
Orthopedic Veterinary Implants Market is projected to reach US$ 3,500 Mn by 2026
Arthritis is a common disorder which has been recently seen spreading its roots dogs. At present, this diseases is treated with the help of orthopedic veterinary implants. The global orthopedic veterinary implants market has witnessed a substantial surge in the last couple years owing to the rise in pet adoption and their orthopedic surgeries. Majority of the population, especially in the developed regions, own pets such as cats or dogs.
Prepackaged Medical Kits and Trays Market is anticipated to Register a CAGR of 8.3% during 2018 – 2026
Prepackaged Medical Kits and Trays Market is anticipated to Register a CAGR of 8 …
There has been a Herculean shift in the healthcare industry towards a reformed model and significant rise in investments worldwide is intended to improve various facilities and services across the healthcare industry. The concept of value-based pricing of pharmaceuticals has gained momentum in the last few years and a majority of the OECD countries have adopted this model. This shift has been a crucial component for the revenue growth of

All 5 Releases


More Releases for Sterile

Evolving Market Trends In The Sterile Endotracheal Tube Industry: Advancements I …
The Sterile Endotracheal Tube Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Sterile Endotracheal Tube Market Size During the Forecast Period? The sterile endotracheal tube market size will grow from $2.14 billion in 2024 to $2.29 billion in 2025 at a compound
Key Trend Reshaping the Sterile Tubing Welder Market in 2025: Innovative Connect …
What industry-specific factors are fueling the growth of the sterile tubing welder market? The expanding biologics pipeline is anticipated to propel the growth of the sterile tubing welder market. Biologics are medicines derived from living organisms or their components, such as vaccines and gene therapies. The growth of biologics is driven by advances in biotechnology and a better understanding of diseases. Sterile tubing welders are used to form biologics, ensuring safe
India's First Robotic 10-Head PFS Filling Machine: Revolutionizing Sterile Pharm …
HMPL Sterile is thrilled to announce the launch of India's first robotic 10-head Pre-Filled Syringe (PFS) filling and closing machine. This cutting-edge innovation is set to transform the landscape of sterile pharmaceutical packaging by offering unmatched precision, efficiency, and compliance with global standards. Engineered to meet the stringent requirements of regulatory bodies like the USFDA and EU GMP, this machine is a game-changer for pharmaceutical manufacturers seeking advanced solutions. A Breakthrough
Sterile Environment: Unveiling the Medical Simple Sterile Room | Inertec, HEMCO, …
Medical Simple Sterile Room Market 2023 Forecast: Unveiling Opportunities and Growth Medical Simple Sterile Room market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Medical Simple Sterile Room market is anticipated to grow at large scale over the forecast period (2023-2029). The main purpose of the study report is to give
Disposable Sterile Surgical Kit Market: Increasing Emphasis on Infection Prevent …
Global Disposable Sterile Surgical Kit Market Overview: The Disposable Sterile Surgical Kit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Disposable Sterile Surgical Kit market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and
Sterile Medical Packaging Market
Trouve360Reports, a leading market research firm, unveils its latest comprehensive report on the global Sterile Medical Packaging market. With an extensive analysis of industry trends, market dynamics, competitive landscape, and regional outlook, the report offers valuable insights to industry stakeholders, investors, and decision-makers. https://www.trouve360reports.com/global-sterile-medical-packaging-market-research-report-2023/ The global Sterile Medical Packaging market is witnessing remarkable growth, driven by the increasing demand for safe and contamination-free healthcare products. The rising awareness about the importance of